Serene has received authority to proceed with its first-in-human RSO Phase 1b trial in Canada, by Health Canada. The “No Objection Letter” from the Biologics and Genetic Therapies Directorate authorizes Serene to begin preparations for the trial with prospective clinical sites in Canada.